{"id":105,"date":"2024-05-28T12:02:34","date_gmt":"2024-05-28T12:02:34","guid":{"rendered":"https:\/\/inimmune.com\/?page_id=105"},"modified":"2025-10-02T15:47:43","modified_gmt":"2025-10-02T15:47:43","slug":"about","status":"publish","type":"page","link":"https:\/\/inimmune.com\/?page_id=105","title":{"rendered":"About"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"105\" class=\"elementor elementor-105\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-cadd236 e-con-full e-flex e-con e-parent\" data-id=\"cadd236\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t<div class=\"elementor-element elementor-element-ca27219 e-con-full e-flex e-con e-child\" data-id=\"ca27219\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t<div class=\"elementor-element elementor-element-8bac1f1 e-con-full e-flex e-con e-child\" data-id=\"8bac1f1\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-fa3ada8 elementor-widget elementor-widget-heading\" data-id=\"fa3ada8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Discovery Focused, Development Driven<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-912e347 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"912e347\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Inimmune\u2019s focus is to discover and develop disease-modifying immunotherapies. Currently, our pipeline includes two clinical-stage Toll-like receptor (TLR) agonists in immuno-oncology and allergy. Both of these TLR agonists generated disease-modifying therapeutic responses in pre-clinical models. Late-stage pre-clinical programs are focused on developing innate immune agonists as next-generation vaccine adjuvants and discovery-stage projects are centered around novel, non-TLR innate immune agonists and antagonists.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-3c1fb11 e-con-full e-flex e-con e-child\" data-id=\"3c1fb11\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e412f89 elementor-widget-mobile__width-initial elementor-widget__width-inherit elementor-widget-laptop__width-initial elementor-widget elementor-widget-image\" data-id=\"e412f89\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"800\" height=\"534\" src=\"https:\/\/inimmune.com\/wp-content\/uploads\/2025\/10\/Group-2025-min-1024x683.jpg\" class=\"attachment-large size-large wp-image-4397\" alt=\"\" srcset=\"https:\/\/inimmune.com\/wp-content\/uploads\/2025\/10\/Group-2025-min-1024x683.jpg 1024w, https:\/\/inimmune.com\/wp-content\/uploads\/2025\/10\/Group-2025-min-300x200.jpg 300w, https:\/\/inimmune.com\/wp-content\/uploads\/2025\/10\/Group-2025-min-768x512.jpg 768w, https:\/\/inimmune.com\/wp-content\/uploads\/2025\/10\/Group-2025-min-1536x1025.jpg 1536w, https:\/\/inimmune.com\/wp-content\/uploads\/2025\/10\/Group-2025-min-2048x1366.jpg 2048w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-61f82d0 e-con-full e-flex e-con e-parent\" data-id=\"61f82d0\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t<div class=\"elementor-element elementor-element-5c4f60b e-con-full e-flex e-con e-child\" data-id=\"5c4f60b\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4241aef elementor-widget__width-inherit elementor-widget elementor-widget-image\" data-id=\"4241aef\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"800\" height=\"533\" src=\"https:\/\/inimmune.com\/wp-content\/uploads\/2024\/05\/science-microscope.jpg\" class=\"attachment-large size-large wp-image-269\" alt=\"\" srcset=\"https:\/\/inimmune.com\/wp-content\/uploads\/2024\/05\/science-microscope.jpg 1020w, https:\/\/inimmune.com\/wp-content\/uploads\/2024\/05\/science-microscope-300x200.jpg 300w, https:\/\/inimmune.com\/wp-content\/uploads\/2024\/05\/science-microscope-768x512.jpg 768w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-7ca78ec e-con-full e-flex e-con e-child\" data-id=\"7ca78ec\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t<div class=\"elementor-element elementor-element-a608e93 e-con-full e-flex e-con e-child\" data-id=\"a608e93\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a5b4acf elementor-widget elementor-widget-heading\" data-id=\"a5b4acf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Meaningful Impacts<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cd42ef9 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"cd42ef9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Inimmune was founded in early 2016 by Drs. Jay Evans, David Burkhart, Helene Bazin-Lee, Kendal Ryter, and a team of 11 highly trained scientists.&nbsp; This team of chemists, immunologists, and formulation scientists have been at the cutting edge of innovation for over 10 years as former GSK Vaccines scientists and investigators. They now are working to create new immunotherapies directed at making meaningful and lasting clinical impacts in the areas of allergy, autoimmunity, infectious disease, and cancer. Through its technology, assets, expertise, and favorable IP positioning, Inimmune is poised to stand up and become a leader in these clinical areas.<br><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-69af5bb e-flex e-con-boxed e-con e-parent\" data-id=\"69af5bb\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;,&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1e48480 elementor-widget elementor-widget-heading\" data-id=\"1e48480\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Driving Immune Therapies Forward<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b8ebf19 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"b8ebf19\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tWe are harnessing the human immune system to create next generation novel immunotherapeutics for the treatment of allergy, infectious disease, autoimmunity and cancer. \t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ad13347 elementor-align-center elementor-widget__width-initial elementor-widget elementor-widget-button\" data-id=\"ad13347\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"\/pipeline\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Our Pipeline<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-ad8b9b0 e-con-full e-flex e-con e-parent\" data-id=\"ad8b9b0\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t<div class=\"elementor-element elementor-element-5f669b0 e-con-full e-flex e-con e-child\" data-id=\"5f669b0\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t<div class=\"elementor-element elementor-element-962484c e-con-full e-flex e-con e-child\" data-id=\"962484c\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7c252cc elementor-widget elementor-widget-heading\" data-id=\"7c252cc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Our Mission<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3a82e71 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"3a82e71\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>We believe in making meaningful and lasting positive clinical impacts for the betterment of humankind. Our team has over 20 years of expertise in discovering and developing safe and effective immunomodulators that can be used to treat a wide variety of diseases and disorders. We have a proven track record of innovation, intellectual property generation, effective collaboration, and sourcing external funding to drive our immune therapies forward.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-38cd784 e-con-full e-flex e-con e-child\" data-id=\"38cd784\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5321c6a elementor-widget elementor-widget-image\" data-id=\"5321c6a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"800\" height=\"479\" src=\"https:\/\/inimmune.com\/wp-content\/uploads\/2024\/05\/doctor-hands-and-vaccine.jpg\" class=\"attachment-large size-large wp-image-273\" alt=\"\" srcset=\"https:\/\/inimmune.com\/wp-content\/uploads\/2024\/05\/doctor-hands-and-vaccine.jpg 1020w, https:\/\/inimmune.com\/wp-content\/uploads\/2024\/05\/doctor-hands-and-vaccine-300x180.jpg 300w, https:\/\/inimmune.com\/wp-content\/uploads\/2024\/05\/doctor-hands-and-vaccine-768x460.jpg 768w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Discovery Focused, Development Driven Inimmune\u2019s focus is to discover and develop disease-modifying immunotherapies. Currently, our pipeline includes two clinical-stage Toll-like receptor (TLR) agonists in immuno-oncology and allergy. Both of these TLR agonists generated disease-modifying therapeutic responses in pre-clinical models. Late-stage pre-clinical programs are focused on developing innate immune agonists as next-generation vaccine adjuvants and discovery-stage [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-105","page","type-page","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.8 - aioseo.com -->\n\t<meta name=\"description\" content=\"Discovery Focused, Development Driven Inimmune\u2019s focus is to discover and develop disease-modifying immunotherapies. Currently, our pipeline includes two clinical-stage Toll-like receptor (TLR) agonists in immuno-oncology and allergy. Both of these TLR agonists generated disease-modifying therapeutic responses in pre-clinical models. Late-stage pre-clinical programs are focused on developing innate immune agonists as next-generation vaccine adjuvants and discovery-stage\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/inimmune.com\/?page_id=105\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.8\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Inimmune - Harnessing the Immune System to Improve Human Health\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"About - Inimmune\" \/>\n\t\t<meta property=\"og:description\" content=\"Discovery Focused, Development Driven Inimmune\u2019s focus is to discover and develop disease-modifying immunotherapies. Currently, our pipeline includes two clinical-stage Toll-like receptor (TLR) agonists in immuno-oncology and allergy. Both of these TLR agonists generated disease-modifying therapeutic responses in pre-clinical models. Late-stage pre-clinical programs are focused on developing innate immune agonists as next-generation vaccine adjuvants and discovery-stage\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/inimmune.com\/?page_id=105\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2024-05-28T12:02:34+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-10-02T15:47:43+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"About - Inimmune\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Discovery Focused, Development Driven Inimmune\u2019s focus is to discover and develop disease-modifying immunotherapies. Currently, our pipeline includes two clinical-stage Toll-like receptor (TLR) agonists in immuno-oncology and allergy. Both of these TLR agonists generated disease-modifying therapeutic responses in pre-clinical models. Late-stage pre-clinical programs are focused on developing innate immune agonists as next-generation vaccine adjuvants and discovery-stage\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/inimmune.com\\\/?page_id=105#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/inimmune.com#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/inimmune.com\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/inimmune.com\\\/?page_id=105#listItem\",\"name\":\"About\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/inimmune.com\\\/?page_id=105#listItem\",\"position\":2,\"name\":\"About\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/inimmune.com#listItem\",\"name\":\"Home\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/inimmune.com\\\/#organization\",\"name\":\"My Blog\",\"description\":\"Harnessing the Immune System to Improve Human Health\",\"url\":\"https:\\\/\\\/inimmune.com\\\/\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/inimmune.com\\\/?page_id=105#webpage\",\"url\":\"https:\\\/\\\/inimmune.com\\\/?page_id=105\",\"name\":\"About - Inimmune\",\"description\":\"Discovery Focused, Development Driven Inimmune\\u2019s focus is to discover and develop disease-modifying immunotherapies. Currently, our pipeline includes two clinical-stage Toll-like receptor (TLR) agonists in immuno-oncology and allergy. Both of these TLR agonists generated disease-modifying therapeutic responses in pre-clinical models. Late-stage pre-clinical programs are focused on developing innate immune agonists as next-generation vaccine adjuvants and discovery-stage\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/inimmune.com\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/inimmune.com\\\/?page_id=105#breadcrumblist\"},\"datePublished\":\"2024-05-28T12:02:34+00:00\",\"dateModified\":\"2025-10-02T15:47:43+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/inimmune.com\\\/#website\",\"url\":\"https:\\\/\\\/inimmune.com\\\/\",\"name\":\"My Blog\",\"description\":\"Harnessing the Immune System to Improve Human Health\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/inimmune.com\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"About - Inimmune","description":"Discovery Focused, Development Driven Inimmune\u2019s focus is to discover and develop disease-modifying immunotherapies. Currently, our pipeline includes two clinical-stage Toll-like receptor (TLR) agonists in immuno-oncology and allergy. Both of these TLR agonists generated disease-modifying therapeutic responses in pre-clinical models. Late-stage pre-clinical programs are focused on developing innate immune agonists as next-generation vaccine adjuvants and discovery-stage","canonical_url":"https:\/\/inimmune.com\/?page_id=105","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/inimmune.com\/?page_id=105#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/inimmune.com#listItem","position":1,"name":"Home","item":"https:\/\/inimmune.com","nextItem":{"@type":"ListItem","@id":"https:\/\/inimmune.com\/?page_id=105#listItem","name":"About"}},{"@type":"ListItem","@id":"https:\/\/inimmune.com\/?page_id=105#listItem","position":2,"name":"About","previousItem":{"@type":"ListItem","@id":"https:\/\/inimmune.com#listItem","name":"Home"}}]},{"@type":"Organization","@id":"https:\/\/inimmune.com\/#organization","name":"My Blog","description":"Harnessing the Immune System to Improve Human Health","url":"https:\/\/inimmune.com\/"},{"@type":"WebPage","@id":"https:\/\/inimmune.com\/?page_id=105#webpage","url":"https:\/\/inimmune.com\/?page_id=105","name":"About - Inimmune","description":"Discovery Focused, Development Driven Inimmune\u2019s focus is to discover and develop disease-modifying immunotherapies. Currently, our pipeline includes two clinical-stage Toll-like receptor (TLR) agonists in immuno-oncology and allergy. Both of these TLR agonists generated disease-modifying therapeutic responses in pre-clinical models. Late-stage pre-clinical programs are focused on developing innate immune agonists as next-generation vaccine adjuvants and discovery-stage","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/inimmune.com\/#website"},"breadcrumb":{"@id":"https:\/\/inimmune.com\/?page_id=105#breadcrumblist"},"datePublished":"2024-05-28T12:02:34+00:00","dateModified":"2025-10-02T15:47:43+00:00"},{"@type":"WebSite","@id":"https:\/\/inimmune.com\/#website","url":"https:\/\/inimmune.com\/","name":"My Blog","description":"Harnessing the Immune System to Improve Human Health","inLanguage":"en-US","publisher":{"@id":"https:\/\/inimmune.com\/#organization"}}]},"og:locale":"en_US","og:site_name":"Inimmune - Harnessing the Immune System to Improve Human Health","og:type":"article","og:title":"About - Inimmune","og:description":"Discovery Focused, Development Driven Inimmune\u2019s focus is to discover and develop disease-modifying immunotherapies. Currently, our pipeline includes two clinical-stage Toll-like receptor (TLR) agonists in immuno-oncology and allergy. Both of these TLR agonists generated disease-modifying therapeutic responses in pre-clinical models. Late-stage pre-clinical programs are focused on developing innate immune agonists as next-generation vaccine adjuvants and discovery-stage","og:url":"https:\/\/inimmune.com\/?page_id=105","article:published_time":"2024-05-28T12:02:34+00:00","article:modified_time":"2025-10-02T15:47:43+00:00","twitter:card":"summary_large_image","twitter:title":"About - Inimmune","twitter:description":"Discovery Focused, Development Driven Inimmune\u2019s focus is to discover and develop disease-modifying immunotherapies. Currently, our pipeline includes two clinical-stage Toll-like receptor (TLR) agonists in immuno-oncology and allergy. Both of these TLR agonists generated disease-modifying therapeutic responses in pre-clinical models. Late-stage pre-clinical programs are focused on developing innate immune agonists as next-generation vaccine adjuvants and discovery-stage"},"aioseo_meta_data":{"post_id":"105","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"seo_analyzer_scan_date":"2025-10-20 13:04:20","breadcrumb_settings":null,"limit_modified_date":false,"open_ai":null,"ai":null,"created":"2024-05-28 12:02:34","updated":"2025-10-20 13:04:20"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/inimmune.com\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tAbout\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/inimmune.com"},{"label":"About","link":"https:\/\/inimmune.com\/?page_id=105"}],"_links":{"self":[{"href":"https:\/\/inimmune.com\/index.php?rest_route=\/wp\/v2\/pages\/105","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inimmune.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/inimmune.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/inimmune.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inimmune.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=105"}],"version-history":[{"count":0,"href":"https:\/\/inimmune.com\/index.php?rest_route=\/wp\/v2\/pages\/105\/revisions"}],"wp:attachment":[{"href":"https:\/\/inimmune.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}